SAB Biotherapeutics (SABS) PT Raised to $10 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts SABS Hot Sheet
Price: $3.75 --0%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Edward White raised the price target on SAB Biotherapeutics (NASDAQ: SABS) to $10.00 (from $1.00) while maintaining a Buy rating.
You May Also Be Interested In
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
- Birkenstock (BIRK) PT Raised to $55 at Bernstein SocGen Group
- Parker-Hannifin (PH) PT Raised to $1,218 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
